Oncopeptides AB(DE:OND)
€0.16-0.01 (-4.88%)
DE:OND
Oncopeptides AB earnings date
€0.16
At close:-0.01 (-4.88%)
Oncopeptides AB (OND) Q2 2021 Earnings Report
6 Followers
DE:OND Q2 2021 EPS Results
- Actual EPS
- -EUR 0.02
- Consensus EPS
- -EUR 3.13
- Beat/Miss
- Beat by +EUR 3.11
- One Year Ago EPS
- -EUR 0.44
DE:OND Q2 2021 Revenue Results
- Actual Revenue
- EUR 5.99M
- Expected Revenue
- EUR 76.33M
- Beat/Miss
- Missed by -EUR 70.34M
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/19/2021
- Time
- Before Open
- Conference Call
- Thursday, August 19, 2021
DE:OND Upcoming Earnings
Oncopeptides AB's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:OND Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | ―- | -0.02 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | ―-0.01 | -0.02 | 54.90% (+0.01) | |
| Aug 27, 2026 | 2026 (Q2) | ―-0.01 | -0.03 | 49.12% (+0.01) | |
| May 13, 2026 | 2026 (Q1) | ―-0.01 | -0.02 | 52.94% (+0.01) | |
| Feb 19, 2026 | 2025 (Q4) | -0.02-0.02 | -0.03 | 31.01% (+0.01) | |
| Nov 05, 2025 | 2025 (Q3) | -0.24-0.02 | -0.02 | 1.16% (+0.00) | |
| Aug 21, 2025 | 2025 (Q2) | ―-0.03 | -0.04 | 33.72% (+0.01) | |
| May 15, 2025 | 2025 (Q1) | ―-0.02 | -0.06 | 61.77% (+0.04) | |
| Feb 27, 2025 | 2024 (Q4) | ―-0.03 | -0.05 | 39.47% (+0.02) | |
| Nov 07, 2024 | 2024 (Q3) | ―-0.02 | -0.03 | 9.15% (+0.00) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
